ClinicalTrials.gg
Not yet recruitingNCT07852104Updated Oct 1, 2026

COMPARISON OF THE EFFECTS OF ERECTOR SPINAE PLANE (ESP) BLOCK AND QUADRO İLİAC PLANE (QIP) BLOCK ON POSTOPERATIVE OPIOID CONSUMPTION AND PAIN IN LUMBAR SPINAL SURGERY

An interventional study of NRS Score and total tramadol consumption in Postoperative Pain Management, sponsored by Aydin Adnan Menderes University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Aydin Adnan Menderes University · Not applicable, Interventional, and Prevention

How we know

Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Pain, Postoperative by Aydin Adnan Menderes University — 6 open to participants now, 7 under way, none of them phase 3. Pain, Postoperative · Aydin Adnan Menderes University.

Planned enrollment
8th of 19
80 · median 80
Started
2026
with 3 others
No phase
15 of 24
6 open now
Registered
22nd of 24
by date

Among the 24 studies in Pain, Postoperative by Aydin Adnan Menderes University, this one is the 8th largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2026, is one of 15 with no phase, and was the 22nd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

6 of the 24 studies in Pain, Postoperative by Aydin Adnan Menderes University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Pain, Postoperative by Aydin Adnan Menderes University, or all of them as a file.
02

Study summary

COMPARISON OF THE EFFECTS OF ERECTOR SPINAE PLANE (ESP) BLOCK AND QUADRO İLİAC PLANE (QIP) BLOCK ON POSTOPERATIVE OPIOID CONSUMPTION AND PAIN IN LUMBAR SPINAL SURGERY

Read the detailed description

The study is designed as a double-blind, prospective, randomized controlled trial. Regarding blinding, the healthcare personnel responsible for monitoring postoperative pain will be unaware of whether the patients received an ESP block or a QIP block. Patient randomization was planned using a computer-based system. Following the operation, once patients are transferred to the postoperative recovery room, their pain levels will be assessed and recorded using the Numeric Rating Scale (NRS) at the following time points: 30 minutes, and 1, 6, 12, and 24 hours. In the ward, patients will receive tramadol via PCA and paracetamol every eight hours. Hourly NRS monitoring is planned during the patient's follow-up in the ward. If the NRS score reaches 4 or higher during this period, 75 mg of diclofenac sodium will be administered intramuscularly, and the number of self-administered bolus doses via PCA (Patient-Controlled Analgesia) within the first 24 hours will be recorded. Opioid consumption and pain levels (via NRS scores) will be evaluated at the 24th postoperative hour for patients in both the ESP and QIP block groups. Additionally, the patients' hemodynamic parameters will be recorded at these time intervals.

03

Conditions studied

  • Postoperative Pain Management

Browse trials for

Keywords

  • Erector spinae region block
  • lumbar spine surgeries
  • opioid consumption
  • quadro iliac plane block
  • postoperative pain
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  1. Undergoing elective lumbar spinal surgery
  2. Aged 18-75 years Exclusion Criteria: - 1. Refusal at the time of enrollment 2. Request to withdraw from the study 3. Inability to provide 4. Emergency surgery 5. Bleeding diathesis 6. Presence of to the local anesthetic (LA) agents used in this study 7. Chronic opioid use 8. Psychiatric disorders 9. Presence of infection at the injection site
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    ESP BLOCK

    Diagnostic Test: NRS Score · Diagnostic Test: total tramadol consumption · Drug: Post Operative Pain Relievers

  • Experimental
    QIP BLOCK

    Diagnostic Test: NRS Score · Diagnostic Test: total tramadol consumption · Drug: Post Operative Pain Relievers

Interventions

  • Diagnostic testNRS Score

    An 11-point Numerical Rating Scale (NRS), where 0 indicated no pain and 10 represented the worst pain imaginable, was used to assess patients' pain levels.

  • Diagnostic testtotal tramadol consumption

    The total number of patient-controlled analgesia (PCA) bolus doses delivered within the first 24 hours will record

  • DrugPost Operative Pain Relievers

    All patients in the ward will be administered intravenous paracetamol every 8 hours, and intramuscular diclofenac sodium (75 mg) if the NRS score is 4 or higher.

    Also known as: DİCLOFENAK SODYUM, PCA İLE TRAMADOL, PARASETAMOL

06

What researchers measure

Primary outcomes

  1. To compare the effects of the Quadro İliac Plane Block and the Erector Spinae Plane (ESP) Block on postoperative opioid consumption in lumbar spinal surgeries

    All patients will be administered tramadol via PCA, and the amount of tramadol consumed will be assessed at the end of the 24-hour postoperative period.

    Time frame: 24 hour

Secondary outcomes

  1. To compare the effects of the Quadro iliac (Qıp) block and the Erector Spinae Plane (ESP) block on postoperative pain in lumbar spinal surgeries

    The NRS score will be assessed on a scale of 0 to 10, with 0 representing the lowest and 10 the highest value; patients will be asked to provide a rating at the 12th hour.

    Time frame: 12th hour

07

Study locations

1 site
  • Aydin Adnan Menderes Üniversitesi Tip Fakültesi Hastanesi
    Aydin, 09100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2027, 15 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 15 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2026
First posted
Oct 1, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Dec 30, 2027
CompletionEst.
Dec 30, 2027
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07852104
Responsible party
SINEM SARI (PROF DR, Aydin Adnan Menderes University) — Principal investigator
First posted
Oct 1, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

SİNEM SARI PROF DR
Contact
sarisinem@yahoo.com
902564441256

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion